Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage ...
New research is raising concerns this Lung Cancer Awareness Month, showing an increase in lung cancer diagnoses among younger ...
A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback